Javier Szwarcberg is Chief Executive Officer of Spruce BioSciences, Inc. (SPRB). The company reported total compensation of $2,910,573 for fiscal year 2025.
| Salary | $610,000 |
|---|---|
| Bonus | $503,250 |
| Stock awards | $1,750,518 |
| Option awards | $41,805 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $5,000 |
| Total | $2,910,573 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Spruce BioSciences, Inc. filed April 9, 2026, accession 0001193125-26-149821.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Javier Szwarcberg this page | Chief Executive Officer | $2,910,573 |
| Samir Gharib | President and Chief Financial Officer | $1,473,211 |
| Kirk Ways | Interim Chief Medical Officer | $1,044,412 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Spruce BioSciences, Inc. compensation brief.
Javier Szwarcberg's compensation sits inside Spruce BioSciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.